5 top ASX 200 shares with 'no credible competition'

ASX 200 stocks that can keep the competition at bay enjoy ongoing market advantages.

| More on:
Economic moat

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

When you're looking to add new S&P/ASX 200 Index (ASX: XJO) shares to your portfolio, one of the key factors to consider is how resilient these blue-chip companies are to competition.

As legendary investor Warren Buffett famously said, "In business, I look for economic castles protected by unbreachable moats."

By that, Warren Buffett is referring to large barriers to entry that make it unattractive for would be competitors to attempt to enter the same market space and steal some of the action.

So, which five ASX 200 shares have the some of the biggest moats?

Read on!

ASX 200 shares with deep moats

Speaking at the Pinnacle Investment Management Group Ltd (ASX: PNI) 2024 Investment Summit, Jolon Knight, investment specialist at Hyperion Asset Management said there was plenty of growth to find on the ASX.

"We do think that the funds of growth give you a unique opportunity to really invest in some of the world's best businesses that are just listed here in Australia." Knight said.

As for those companies with yawning moats that Warren Buffett would likely approve of, Knight listed five ASX 200 shares with "no credible competition".

"We look at companies that have no credible competition, such as WiseTech Global Ltd (ASX: WTC), ResMed Inc (ASX: RMD), Cochlear Ltd (ASX: COH), Pro Medicus Ltd (ASX: PME), and REA Group Ltd (ASX: REA)," he said.

Knight noted that Hyperion had held all five ASX 200 shares "for a very long period of time"

The fund added REA Group to its holdings in 2004.

That investment will have paid off very handsomely over the past 20 years. The REA Group share price has skyrocketed an eye-popping 23,047% since mid-August 2004. Meaning a $5,000 investment back then would be worth $115.74 million today.

"They're really high-quality businesses, monopolistic in nature, with no credible competitor," Knight said of all five ASX 200 shares.

"And then when we think about the actual footprint, where these companies are able to sell their products into, almost every single company has a global revenue base," he added.

What companies has Hyperion been buying lately?

As for the ASX 200 shares (and All Ords shares) Hyperion has added to its portfolio over the past eight months, Knight said the fund had bought Goodman Group (ASX: GMG), Lovisa Holdings Ltd (ASX: LOV) and Guzman Y Gomez (ASX: GYG).

"I think we own about 10% of GYG today, and that's in both the Australian Growth Companies Fund and the Small Growth Companies Fund," Knight said.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear, Goodman Group, Lovisa, Pinnacle Investment Management Group, Pro Medicus, REA Group, ResMed, and WiseTech Global. The Motley Fool Australia has positions in and has recommended Pinnacle Investment Management Group, ResMed, and WiseTech Global. The Motley Fool Australia has recommended Cochlear, Goodman Group, Lovisa, Pro Medicus, and REA Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

Blue chips falling.
Share Market News

Shares vs. property: Why are these 2 blue chip investments losing value?

Melbourne is the 3rd cheapest capital city property market in the country, while BHP shares have fallen 23% in 2024.…

Read more »

A group of people in business attire stand in a line against a wall, each with considered expressions on their faces, and superimposed above them a montage of graphs, charts, figures and metrics.
Blue Chip Shares

4 reasons why ASX blue-chip shares can make better buys than growth shares

Here’s why I like ASX blue-chip shares.

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Blue Chip Shares

Forget CBA shares and buy these ASX 200 blue chips

Analysts are bullish on these blue chip stocks. Let's see what they are saying.

Read more »

A steel worker peers out from under his protective headwear which is tipped back on his head as he stares solemnly straight ahead with steel production equipment in the background.
Blue Chip Shares

2 reasons this boring ASX blue-chip share could be a steal deal

The ASX 200 stock has dropped 17% since April, but this expert forecasts better days ahead.

Read more »

Successful group of people applauding in a business meeting and looking very happy.
Blue Chip Shares

3 ASX 200 blue chip shares to buy in September

Analysts have good things to say about these blue chips.

Read more »

Three people in a corporate office pour over a tablet, ready to invest.
Blue Chip Shares

3 ASX 200 shares to buy and hold for a decade

Analysts rate these stocks as buys. Here's why they could be great long term options.

Read more »

A young woman lifts her red glasses with one hand as she takes a closer look at news about interest rates rising and one expert's surprising recommendation as to which ASX shares to buy
Blue Chip Shares

Buy ResMed and these top ASX 200 blue chip shares

Analysts have good things to say about these quality companies.

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Blue Chip Shares

2 high-quality ASX 200 shares to buy and hold forever

Analysts have put buy ratings on these top stocks.

Read more »